MRNS logo

Marinus Pharmaceuticals (MRNS) Company Overview

Profile

Full Name:

Marinus Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 31, 2014

Indexes:

Not included

Description:

Marinus Pharmaceuticals is a biopharmaceutical company focused on developing treatments for rare neurological disorders. Their main product, ZTALMY, is used to treat seizures associated with a specific condition called CDKL5 deficiency disorder. The company aims to improve the lives of patients with challenging medical needs.

Key Details

Price

$0.55

Annual Revenue

$30.99 M(+21.63% YoY)

Annual EPS

-$2.63(-415.69% YoY)

Annual ROE

-213.02%

Beta

1.31

Events Calendar

Earnings

Next earnings date:

Mar 5, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 5, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 23, 2020

Analyst ratings

Recent major analysts updates

Nov 14, 24 HC Wainwright & Co.
Neutral
Nov 14, 24 Cantor Fitzgerald
Overweight
Oct 25, 24 TD Cowen
Hold
Oct 25, 24 RBC Capital
Sector Perform
Oct 25, 24 Jefferies
Hold
Oct 25, 24 HC Wainwright & Co.
Neutral
Oct 25, 24 Cantor Fitzgerald
Overweight
Oct 24, 24 JMP Securities
Market Perform
Oct 24, 24 EF Hutton
Buy
Aug 14, 24 Ladenburg Thalmann
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Marinus Pharmaceuticals?
  • Does Marinus Pharmaceuticals pay dividends?
  • What sector is Marinus Pharmaceuticals in?
  • What industry is Marinus Pharmaceuticals in?
  • What country is Marinus Pharmaceuticals based in?
  • When did Marinus Pharmaceuticals go public?
  • Is Marinus Pharmaceuticals in the S&P 500?
  • Is Marinus Pharmaceuticals in the NASDAQ 100?
  • Is Marinus Pharmaceuticals in the Dow Jones?
  • When was Marinus Pharmaceuticals's last earnings report?
  • When does Marinus Pharmaceuticals report earnings?
  • Should I buy Marinus Pharmaceuticals stock now?

What is the ticker symbol for Marinus Pharmaceuticals?

The ticker symbol for Marinus Pharmaceuticals is NASDAQ:MRNS

Does Marinus Pharmaceuticals pay dividends?

No, Marinus Pharmaceuticals does not pay dividends

What sector is Marinus Pharmaceuticals in?

Marinus Pharmaceuticals is in the Healthcare sector

What industry is Marinus Pharmaceuticals in?

Marinus Pharmaceuticals is in the Biotechnology industry

What country is Marinus Pharmaceuticals based in?

Marinus Pharmaceuticals is headquartered in United States

When did Marinus Pharmaceuticals go public?

Marinus Pharmaceuticals's initial public offering (IPO) was on July 31, 2014

Is Marinus Pharmaceuticals in the S&P 500?

No, Marinus Pharmaceuticals is not included in the S&P 500 index

Is Marinus Pharmaceuticals in the NASDAQ 100?

No, Marinus Pharmaceuticals is not included in the NASDAQ 100 index

Is Marinus Pharmaceuticals in the Dow Jones?

No, Marinus Pharmaceuticals is not included in the Dow Jones index

When was Marinus Pharmaceuticals's last earnings report?

Marinus Pharmaceuticals's most recent earnings report was on Nov 12, 2024

When does Marinus Pharmaceuticals report earnings?

The next expected earnings date for Marinus Pharmaceuticals is Mar 5, 2025

Should I buy Marinus Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions